Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.8655 |
High Similarity |
NPD3818 |
Discontinued |
0.8471 |
Intermediate Similarity |
NPD1247 |
Approved |
0.8457 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8452 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8443 |
Intermediate Similarity |
NPD2801 |
Approved |
0.8383 |
Intermediate Similarity |
NPD1934 |
Approved |
0.8372 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.8304 |
Intermediate Similarity |
NPD5494 |
Approved |
0.8246 |
Intermediate Similarity |
NPD919 |
Approved |
0.8239 |
Intermediate Similarity |
NPD7074 |
Phase 3 |
0.8202 |
Intermediate Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8182 |
Intermediate Similarity |
NPD7054 |
Approved |
0.8136 |
Intermediate Similarity |
NPD7472 |
Approved |
0.8118 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8103 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.8086 |
Intermediate Similarity |
NPD2344 |
Approved |
0.8081 |
Intermediate Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.8068 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.8012 |
Intermediate Similarity |
NPD1511 |
Approved |
0.8011 |
Intermediate Similarity |
NPD6166 |
Phase 2 |
0.8011 |
Intermediate Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8011 |
Intermediate Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8 |
Intermediate Similarity |
NPD7808 |
Phase 3 |
0.7989 |
Intermediate Similarity |
NPD6797 |
Phase 2 |
0.7978 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.7977 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7976 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7976 |
Intermediate Similarity |
NPD920 |
Approved |
0.7965 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.7944 |
Intermediate Similarity |
NPD7251 |
Discontinued |
0.7919 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.7917 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7892 |
Intermediate Similarity |
NPD2309 |
Approved |
0.7857 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7841 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7818 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7798 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7758 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7753 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7751 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.7744 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7738 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7727 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.7716 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7714 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7714 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7701 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7701 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.7692 |
Intermediate Similarity |
NPD6799 |
Approved |
0.768 |
Intermediate Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.767 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.7665 |
Intermediate Similarity |
NPD2800 |
Approved |
0.7647 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.763 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.763 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.7624 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7622 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7619 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.76 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.759 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.759 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7586 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.756 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7557 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7557 |
Intermediate Similarity |
NPD5402 |
Approved |
0.7545 |
Intermediate Similarity |
NPD2343 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7544 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7544 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7544 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7543 |
Intermediate Similarity |
NPD37 |
Approved |
0.7542 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7514 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7514 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD943 |
Approved |
0.7487 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7485 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7474 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.7455 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7447 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.7443 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7432 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7412 |
Intermediate Similarity |
NPD3750 |
Approved |
0.736 |
Intermediate Similarity |
NPD2296 |
Approved |
0.7349 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7349 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7314 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7308 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7251 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7219 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7209 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7208 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7208 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7196 |
Intermediate Similarity |
NPD8312 |
Approved |
0.7196 |
Intermediate Similarity |
NPD8313 |
Approved |
0.7195 |
Intermediate Similarity |
NPD9494 |
Approved |
0.7181 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7178 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7169 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7159 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7151 |
Intermediate Similarity |
NPD6280 |
Approved |
0.7151 |
Intermediate Similarity |
NPD7893 |
Clinical (unspecified phase) |
0.7151 |
Intermediate Similarity |
NPD6279 |
Approved |
0.715 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.715 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7143 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7135 |
Intermediate Similarity |
NPD1471 |
Phase 3 |
0.7121 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.712 |
Intermediate Similarity |
NPD6808 |
Phase 2 |
0.7118 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7118 |
Intermediate Similarity |
NPD651 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD1509 |
Clinical (unspecified phase) |
0.7118 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7112 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.71 |
Intermediate Similarity |
NPD7698 |
Approved |
0.71 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.71 |
Intermediate Similarity |
NPD7697 |
Approved |
0.71 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7098 |
Intermediate Similarity |
NPD4287 |
Approved |
0.709 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7083 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7081 |
Intermediate Similarity |
NPD5242 |
Approved |
0.7053 |
Intermediate Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.705 |
Intermediate Similarity |
NPD5006 |
Approved |
0.705 |
Intermediate Similarity |
NPD5005 |
Approved |
0.7048 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7035 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7027 |
Intermediate Similarity |
NPD7229 |
Phase 3 |
0.7027 |
Intermediate Similarity |
NPD5710 |
Approved |
0.7027 |
Intermediate Similarity |
NPD5711 |
Approved |
0.7024 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7024 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7017 |
Intermediate Similarity |
NPD5760 |
Phase 2 |
0.7017 |
Intermediate Similarity |
NPD5761 |
Phase 2 |
0.7006 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.6988 |
Remote Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.6983 |
Remote Similarity |
NPD7458 |
Discontinued |
0.6979 |
Remote Similarity |
NPD7090 |
Clinical (unspecified phase) |
0.697 |
Remote Similarity |
NPD1203 |
Approved |
0.6964 |
Remote Similarity |
NPD2313 |
Discontinued |
0.6961 |
Remote Similarity |
NPD7701 |
Phase 2 |
0.6957 |
Remote Similarity |
NPD5537 |
Clinical (unspecified phase) |
0.6954 |
Remote Similarity |
NPD6534 |
Approved |
0.6954 |
Remote Similarity |
NPD6535 |
Approved |
0.6949 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6941 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6935 |
Remote Similarity |
NPD4420 |
Approved |
0.6928 |
Remote Similarity |
NPD2798 |
Approved |
0.6901 |
Remote Similarity |
NPD6651 |
Approved |
0.6893 |
Remote Similarity |
NPD7874 |
Approved |
0.6893 |
Remote Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.6893 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6881 |
Remote Similarity |
NPD6823 |
Phase 2 |
0.6879 |
Remote Similarity |
NPD6100 |
Approved |
0.6879 |
Remote Similarity |
NPD6099 |
Approved |
0.6875 |
Remote Similarity |
NPD6190 |
Approved |
0.6864 |
Remote Similarity |
NPD3764 |
Approved |
0.6862 |
Remote Similarity |
NPD2403 |
Approved |
0.686 |
Remote Similarity |
NPD7801 |
Approved |
0.6854 |
Remote Similarity |
NPD7422 |
Clinical (unspecified phase) |
0.685 |
Remote Similarity |
NPD7700 |
Phase 2 |
0.685 |
Remote Similarity |
NPD7699 |
Phase 2 |
0.6848 |
Remote Similarity |
NPD4379 |
Clinical (unspecified phase) |
0.6847 |
Remote Similarity |
NPD7680 |
Approved |
0.6845 |
Remote Similarity |
NPD6832 |
Phase 2 |
0.6845 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6831 |
Remote Similarity |
NPD8455 |
Phase 2 |
0.6829 |
Remote Similarity |
NPD7584 |
Approved |
0.6818 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6813 |
Remote Similarity |
NPD6386 |
Approved |
0.6813 |
Remote Similarity |
NPD6385 |
Approved |
0.6793 |
Remote Similarity |
NPD5353 |
Approved |
0.6789 |
Remote Similarity |
NPD2163 |
Approved |
0.6788 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6788 |
Remote Similarity |
NPD1608 |
Approved |
0.6788 |
Remote Similarity |
NPD9717 |
Approved |
0.6787 |
Remote Similarity |
NPD4846 |
Phase 2 |
0.6772 |
Remote Similarity |
NPD4575 |
Clinical (unspecified phase) |
0.6765 |
Remote Similarity |
NPD4907 |
Clinical (unspecified phase) |
0.6758 |
Remote Similarity |
NPD7028 |
Phase 2 |
0.6744 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6736 |
Remote Similarity |
NPD3658 |
Clinical (unspecified phase) |
0.6734 |
Remote Similarity |
NPD6212 |
Phase 3 |
0.6734 |
Remote Similarity |
NPD6213 |
Phase 3 |
0.6734 |
Remote Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.6733 |
Remote Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.6729 |
Remote Similarity |
NPD7907 |
Approved |
0.6727 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6727
|
Remote Similarity |
NPD3705 |
Approved |